Skip to Main Content

Paper Details

Inhibition of HSP 90 is associated with potent anti-tumor activity in Papillary Renal Cell Carcinoma.
J Exp Clin Cancer Res
4
2022
2D, AKT, AKT1/2, E2F, ERK1/2, G2M-associated genes, HSP 90, HSP90, MEK, MET, MET gene, MET tyrosine kinase, MYC, PI3K, PRCC, PRCC cell lines, PRCC cells, PRCC lines, Papillary Renal Cell Carcinoma, RNA, SNX-2112, SNX2112, cancer, chromosome 7, human, human PRCC xenograft, mice, pAKT1/2, pERK1/2, papillary RCC, papillary renal cell carcinoma, patient, patient derived PRCC cell lines, patients, tumor, tyrosine, xenograft models
Author NameAffiliation
Craig J ThomasDivision of Pre-Clinical Innovation, National Center for Advancing Translational Sciences (NCATS)
Michele CeribelliDivision of Pre-Clinical Innovation, National Center for Advancing Translational Sciences (NCATS)
Christopher J RickettsCenter for Cancer Research, National Cancer Institute, National Institutes of Health
William Marston LinehanCenter for Cancer Research, National Cancer Institute, National Institutes of Health
  • 1 - 4

Datasets

Release 1.2